Clinical Roundup Even light daily physical activity linked to lower cancer risk, NIH and Oxford study shows March 28, 2025Vol.51 No.12
Clinical Roundup Study reinforces Tagrisso as the backbone therapy for EGFR-mutated lung cancer March 28, 2025Vol.51 No.12
Clinical Roundup Pandemic caused temporary disruptions in CRC screening and minimal impact on diagnosis, two studies show March 28, 2025Vol.51 No.12
Clinical Roundup Investigational Orca-T treatment for hematologic malignancies meets primary endpoint in phase III trial March 28, 2025Vol.51 No.12
Clinical Roundup UT Health San Antonio-led research discovers how to slow or block recurrence of glioblastoma March 28, 2025Vol.51 No.12
Clinical Roundup Mutated cells can persist for years without becoming cancer and need an inflammatory “push” for malignancy to occur, COH study shows March 28, 2025Vol.51 No.12
Clinical Roundup AI tool helps predict who will benefit from focal therapy for prostate cancer, study shows March 21, 2025Vol.51 No.11
Clinical Roundup Shorter radiation treatment approach shows safety and efficacy for early-stage prostate cancer March 21, 2025Vol.51 No.11
Clinical Roundup Elahere shows survival benefit in long-term analysis for ovarian cancer patients in phase III study March 21, 2025Vol.51 No.11
Clinical Roundup Genmab’s Rina-S shows promise in treating advanced ovarian cancer March 21, 2025Vol.51 No.11
